Domaplasma B.V. Competitors

At Daiichi Sankyo, we believe progress depends on asking more of science. We are 20,000 people across 30 countries, united by the courage to challenge assumptions and pursue better answers. Across oncology and beyond, we develop new medicines and new approaches to discovery and delivery, addressing unmet medical needs and bringing treatment options within reach. Since 1899, curiosity, rigor and perseverance have shaped how we work. Behind every treatment is a person, a family and a future. That human purpose drives us to keep learning, questioning and advancing science for patients around the world. For more information, please visit www.daiichisankyo.com See our community guidelines here: https://www.daiichisankyo.com/community_guidelines/index.html

Each year, millions of people hear the words no one wants to hear: "You have cancer." And behind each diagnosis lies a unique story, a family that deserves hope, a future that's worth fighting for. We know that no two treatment journeys are the same and delivering care is far from simple. It's complex, urgent, and deeply human. That’s why we don’t back down from challenges—we rise to them. From the smallest tumor change to the toughest clinical decisions, we see every obstacle as an opportunity to progress. That is what drives us. The people undergoing treatment. The clinicians providing the care. We are united in purpose. Together, we can create a world where every patient has access to the highest standard of care. This is our commitment because for everyone, it's personal. We are leading the innovation in personalized radiation therapy solutions. We are Elekta. Elekta reserves the right to remove any comment and to restrict access to its page at its sole discretion, without prior notice. The presence of user comments does not imply endorsement by Elekta, and Elekta makes no representations regarding the accuracy of such comments. User-generated content does not necessarily reflect the views, values, or positions of Elekta.

At Xellia Pharmaceuticals, for more than 120 years, we’ve focused on one thing: making anti-infective medicines the world depends on — reliably, consistently, and at scale. We build partnerships and relationships that matter. The truth is, in this category, supply is not just operational. It’s critical. Fermentation-based manufacturing is complex. It requires deep expertise, long-term investment, and the ability to manage uncertainty over time. The molecules cannot be rushed — and neither can the decisions behind them. That’s why our role goes beyond production. We work with you to ensure continuity — anticipating challenges, adapting as requirements evolve, and staying aligned as the landscape shifts.